Chinese guidelines for the diagnosis and treatment of Craniopharyngioma in children (2025)
Cancer Letters · 2026-10 · 659 · 218784
DOI: 10.1016/j.canlet.2026.218784 ↗Kurz gefasst
Leitlinie in der Zeitschrift Cancer Letters, 2026-10. Verfasst von Zhixiong Lin und 42 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, 100093, China. Electronic address: linzx@ccmu.edu.cn. Hauptthemen laut MEDLINE: Craniopharyngioma, Pituitary Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Foundation for Innovative Research Groups of the National Natural Science Foundation of China.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
This guideline was developed under the auspices of the Pediatric Neurosurgery Group of the Neurosurgery Branch of the Chinese Medical Association, the Neuro-oncology Expert Committee of the Chinese Society of Clinical Oncology, and the Neuro-oncology Professional Committee of the China Anti-Cancer Association. Craniopharyngioma is the most common tumor in the sellar turcica region among children, with the majority being adamantinomatous craniopharyngioma (ACP) and a smaller proportion being papillary craniopharyngioma (PCP). Management of craniopharyngioma involves not only tumor control but also the treatment of tumor-related hypothalamic dysfunction and pituitary endocrine disorders. To standardize the diagnosis and management of pediatric craniopharyngioma, this guideline incorporates evidence from 398 literature references. It provides recommendations on diagnostic evaluation, surgical strategies, radiotherapy principles, prognostic assessment, follow-up and long-term management, and targeted therapy. This guideline is intended to serve as a reference for healthcare professionals engaged in pediatric neuro-oncology. Recommendations were developed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, taking into account the quality of evidence, clinical applicability, and expert consensus. Key recommendations are supported by explanatory rationale. The guideline were reviewed and approved by 35 multidisciplinary experts and 6 external reviewers, followed by formal voting on each recommendation. For areas lacking high-quality evidences, future well-designed clinical trials are recommended to validate and update these recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, 100093, China. Electronic address: linzx@ccmu.edu.cn.
- Department of Neurosurgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200100, China. Electronic address: majie@xinhuamed.com.cn.
- Department of Neurosurgery/Neuro-oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. Elect…
- Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. Electronic address: qisongtaosjwk@163.com.
- Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, Tsinghua University, Tsinghua University School of Clinical Medicine, Beijing, 102218, China. Electronic address: ydenny@126.com.
- Department of Neurosurgery, West China Hospital of Sichuan University, Chengdu, 610044, China. Electronic address: xujg@scu.edu.cn.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- Science and Technology Planning Project of Guangdong Province
Zitieren
APA
Lin, Z., Ma, J., Mou, Y., Qi, S., Yang, X., Xu, J., Lin, Y., Liu, Y., Zhao, C., An, W., Wan, F., Gui, S., Zeng, G., Liang, P., Chen, Y., Zhao, Y., Zhu, M., Li, C., Gong, J., …, & Zhang, B. (2026). Chinese guidelines for the diagnosis and treatment of Craniopharyngioma in children (2025). Cancer Letters, 659, 218784. https://doi.org/10.1016/j.canlet.2026.218784
Vancouver
Lin Z, Ma J, Mou Y, Qi S, Yang X, Xu J, et al. Chinese guidelines for the diagnosis and treatment of Craniopharyngioma in children (2025). Cancer Letters. 2026;659:218784. doi:10.1016/j.canlet.2026.218784
BibTeX
@article{Lin2026,
author = {Lin, Zhixiong and Ma, Jie and Mou, Yonggao and Qi, Songtao and Yang, Xuejun and Xu, Jianguo and Lin, Yi and Liu, Yi and Zhao, Chuan and An, Wenhao and Wan, Feng and Gui, Songbai and Zeng, Gao and Liang, Ping and Chen, Yiguang and Zhao, Yang and Zhu, Mingwang and Li, Chunde and Gong, Jian and Wang, Yongxin and Wang, Yaming and Zhao, Jie and Ju, Yan and Song, Ye and He, Xiaosheng and Wang, Xingfu and Yan, Xiaofang and Qiu, Xianxin and Li, Hao and Wang, Yang and Zhang, Rong and Gong, Jie and Qi, Xueling and Ge, Ming and Wang, Julei and Li, Qingguo and Fan, Jun and Jiang, Xiaobing and Sun, Shibin and Mei, Wenzhong and Fang, Zheming and Han, Song and Zhang, Bo},
title = {Chinese guidelines for the diagnosis and treatment of Craniopharyngioma in children (2025)},
journal = {Cancer Letters},
year = {2026},
volume = {659},
pages = {218784},
doi = {10.1016/j.canlet.2026.218784}
}
EUVIMED